(Q37385799)

20 August 2017

1 reference

title

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis (English)

1 reference

20 August 2017

0 references

0 references

2

Robert H Dworkin

1 reference

20 August 2017

Lahar R Mehta

1

1 reference

20 August 2017

Steven R Schwid

series ordinal

3

1 reference

20 August 2017

language of work or name

1 reference

1 February 2009

1 reference

Nature Clinical Practice Neurology

20 August 2017

published in

1 reference

20 August 2017

volume

5

1 reference

20 August 2017

issue

2

1 reference

20 August 2017

page(s)

82-92

1 reference

Vitamin D intake and incidence of multiple sclerosis

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO1009

Omega-3 Fatty Acids and PPARgamma in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO1009

NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO1009

Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle

21 January 2018

1 reference

12 December 2020

Studies on multiple sclerosis in Winnepeg, Manitoba, and New Orleans, Louisiana. I. Prevalence; comparison between the patient groups in Winnipeg and New Orleans

1 reference

12 December 2020

Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients.

1 reference

12 December 2020

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers

1 reference

12 December 2020

Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada

1 reference

12 December 2020

Botanical lipids: potential role in modulation of immunologic responses and inflammatory reactions

1 reference

12 December 2020

Antioxidants and polyunsaturated fatty acids in multiple sclerosis

1 reference

12 December 2020

The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production

1 reference

12 December 2020

Dietary interventions for multiple sclerosis

1 reference

12 December 2020

FURTHER NOTES ON DISABILITY EVALUATION IN MULTIPLE SCLEROSIS, WITH SCALE MODIFICATIONS

1 reference

12 December 2020

Nutrition, latitude, and multiple sclerosis mortality: an ecologic study

1 reference

12 December 2020

Recent advances in the biology of n-6 fatty acids

1 reference

12 December 2020

Treatment of multiple sclerosis with low-fat diet: result of seven years' experience

1 reference

12 December 2020

Linoleic acid levels in white blood cells, platelets, and serum of multiple sclerosis patients

1 reference

12 December 2020

Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis

1 reference

12 December 2020

The opposing effects of n-3 and n-6 fatty acids

1 reference

12 December 2020

Disease-modifying therapy in MS: a critical review of the literature. Part I: Analysis of clinical trial errors

1 reference

12 December 2020

Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis

1 reference

12 December 2020

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

12 December 2020

Polyunsaturated fatty acids: From diet to binding to ppars and other nuclear receptors

1 reference

12 December 2020

On the evaluation of disability in multiple sclerosis

1 reference

12 December 2020

Epidemiological study of multiple sclerosis in western Poland

1 reference

12 December 2020

Multiple Sclerosis: Twenty Years on Low Fat Diet

1 reference

12 December 2020

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

1 reference

12 December 2020

Effect of low saturated fat diet in early and late cases of multiple sclerosis.

1 reference

12 December 2020

Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit

1 reference

12 December 2020

IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues

1 reference

12 December 2020

Effects of gammalinolenic acid on interleukin-1 beta and tumor necrosis factor-alpha secretion by stimulated human peripheral blood monocytes: studies in vitro and in vivo

1 reference

12 December 2020

Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids

1 reference

12 December 2020

Unconventional therapy in multiple sclerosis.

1 reference

12 December 2020

Multiple sclerosis and MaxEPA

1 reference

12 December 2020

The beneficial and detrimental effects of linoleic acid on autoimmune disorders

1 reference

12 December 2020

Polyunsaturated fatty acid supplementation in MS.

1 reference

12 December 2020

Erythrocyte membrane fatty acids in benign and progressive forms of multiple sclerosis

1 reference

12 December 2020

The role of MRI as a surrogate outcome measure in multiple sclerosis

1 reference

12 December 2020

Prevention of experimental autoimmune encephalomyelitis in Lewis rats by a novel fungal source of gamma-linolenic acid

1 reference

12 December 2020

The immunological functions of the vitamin D endocrine system.

1 reference

12 December 2020

Regression to the mean in multiple sclerosis

1 reference

12 December 2020

Polyunsaturated fatty acids increase neutrophil adherence and integrin receptor expression

1 reference

12 December 2020

Essential fatty acids and related molecular and cellular mechanisms in multiple sclerosis: new looks at old concepts.

1 reference

12 December 2020

Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.

1 reference

12 December 2020

Oleanolic acid induces prostacyclin release in human vascular smooth muscle cells through a cyclooxygenase-2-dependent mechanism

1 reference

12 December 2020

Long-term treatment of multiple sclerosis with corticotrophin

1 reference

12 December 2020

Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma

1 reference

12 December 2020

NF-kappaB and the immune response

1 reference

12 December 2020

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis

1 reference

12 December 2020

Eicosapentaenoic acid stimulates the expression of myelin proteins in rat brain.

1 reference

12 December 2020

Dietary fatty acids and allergy

1 reference

12 December 2020

Alteration of polyunsaturated fatty acid status and metabolism in health and disease.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women.

1 reference

12 December 2020

Linoleic acid therapy in severe experimental allergic encephalomyelitis in the guinea-pig: suppression by continuous treatment.

1 reference

12 December 2020

The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells

1 reference

12 December 2020

Clinical trials of multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets

1 reference

12 December 2020

From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

1 reference

12 December 2020

Complementary and alternative medicine for multiple sclerosis

1 reference

12 December 2020

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study

1 reference

12 December 2020

Neutrophil migration inhibitory properties of polyunsaturated fatty acids. The role of fatty acid structure, metabolism, and possible second messenger systems

1 reference

12 December 2020

Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells--implications for complementary multiple sclerosis treatment

1 reference

12 December 2020

Botanical lipids: effects on inflammation, immune responses, and rheumatoid arthritis

1 reference

12 December 2020

Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3.

1 reference

12 December 2020

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

1 reference

12 December 2020

Environmental risk factors in MS: a case-control study in Moscow.

1 reference

12 December 2020

Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy.

1 reference

12 December 2020

Review of MS patient survival on a Swank low saturated fat diet

1 reference

12 December 2020

Prostaglandins and cell-mediated immunity. The role of prostaglandin E1 in the induction of host-versus-graft and graft-versus-host reactions in mice

1 reference

12 December 2020

Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig

1 reference

12 December 2020

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis

1 reference

12 December 2020

Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production

1 reference

12 December 2020

Lipid and fatty acid composition is altered in plaque tissue from multiple sclerosis brain compared with normal brain white matter

1 reference

12 December 2020

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

1 reference

12 December 2020

Double-blind Trial of Linoleic Acid in Multiple Sclerosis

1 reference

12 December 2020

Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders

1 reference

12 December 2020

Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases

1 reference

12 December 2020

New regulators of NF-kappaB in inflammation

1 reference

12 December 2020

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

1 reference

12 December 2020

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1

1 reference

12 December 2020

Oral administration of unsaturated fatty acids: effects on human peripheral blood T lymphocyte proliferation

1 reference

12 December 2020

Double-blind Trial of Linoleate Supplementation of the Diet in Multiple Sclerosis

1 reference

12 December 2020

Minor polar compounds extra-virgin olive oil extract (MPC-OOE) inhibits NF-kappa B translocation in human monocyte/macrophages.

1 reference

12 December 2020

Polyunsaturated fatty acids and inflammatory diseases.

1 reference

12 December 2020

Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis

1 reference

12 December 2020

Nutrition and immunity: the immunoregulatory effect of n-6 essential fatty acids is mediated through prostaglandin E.

1 reference

12 December 2020

Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients

1 reference

12 December 2020

New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases

1 reference

12 December 2020

Treatment of multiple sclerosis with low-fat diet; results of five and one-half years' experience

1 reference

12 December 2020

The emerging role of MRI in multiple sclerosis and the new diagnostic criteria

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO1009

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/NCPNEURO1009

1 reference

20 August 2017

1 reference